Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:453752.
doi: 10.1155/2015/453752. Epub 2015 Apr 9.

Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration

Affiliations

Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration

Jordi Gascon-Bayarri et al. Case Rep Neurol Med. 2015.

Abstract

Ornithine transcarbamylase deficiency (OTCD) is a rare X-linked disorder of urea synthesis leading to hyperammonemia. Several late-onset cases have been reported. Undiagnosed and untreated patients are at the risk of death or suffering from irreversible sequelae. We describe a 56-year-old patient who presented with acute encephalopathy after steroid treatment. Hyperammonemia due to OTCD was diagnosed and a mutation was found. This allowed us to diagnose two other family members with unexplained encephalopathy who are now asymptomatic on a low-protein diet. OTCD should be considered in any patient with hyperammonemic encephalopathy and immediate treatment should be given to avoid a fatal outcome. We emphasize the need to examine other family members if the diagnosis is confirmed, in order to prevent further life-threatening episodes of encephalopathy or neonatal coma of newborn.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Family tree. Subjects x and y are affected carriers. Subject z has two carrier daughters and is suspected to have been an affected carrier.

References

    1. Panlaqui O. M., Tran K., Johns A., McGill J., White H. Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency. Intensive Care Medicine. 2008;34(10):1922–1924. doi: 10.1007/s00134-008-1217-2. - DOI - PubMed
    1. Rüegger C. M., Lindner M., Ballhausen D., et al. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. Journal of Inherited Metabolic Disease. 2014;37(1):21–30. doi: 10.1007/s10545-013-9624-0. - DOI - PMC - PubMed
    1. Cavicchi C., Donati M., Parini R., et al. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Orphanet Journal of Rare Diseases. 2014;9, article 105 doi: 10.1186/s13023-014-0105-9. - DOI - PMC - PubMed
    1. Heringlake S., Böker K., Manns M. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient. Digestion. 1997;58(1):83–86. doi: 10.1159/000201428. - DOI - PubMed
    1. Roberts D. L., Galbreath D. A., Patel B. M., Ingall T. J., Khatib A., Johnson D. J. Hyperammonemic coma in an adult due to ornithine transcarbamylase deficiency. Case Reports in Critical Care. 2013;2013:4. doi: 10.1155/2013/493216.493216 - DOI - PMC - PubMed